Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17774) 17774
Newspaper Article (809) 809
Newsletter (514) 514
Book Chapter (440) 440
Magazine Article (38) 38
Dissertation (12) 12
Publication (8) 8
Transcript (8) 8
Web Resource (6) 6
Trade Publication Article (4) 4
Book / eBook (3) 3
Conference Proceeding (3) 3
Report (3) 3
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14594) 14594
science & technology (13261) 13261
life sciences & biomedicine (12906) 12906
male (10218) 10218
female (9964) 9964
middle aged (8556) 8556
adult (7908) 7908
oncology (7138) 7138
aged (6917) 6917
lymphoma (6289) 6289
hematology (5900) 5900
biological and medical sciences (5021) 5021
medical sciences (4998) 4998
prognosis (4306) 4306
cancer (4083) 4083
adolescent (3835) 3835
lymphomas (3703) 3703
chemotherapy (3393) 3393
hematologic and hematopoietic diseases (3327) 3327
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (3244) 3244
antineoplastic combined chemotherapy protocols - therapeutic use (3240) 3240
treatment outcome (3190) 3190
retrospective studies (2959) 2959
aged, 80 and over (2921) 2921
lymphoma, non-hodgkin - mortality (2689) 2689
survival rate (2628) 2628
non-hodgkin's lymphomas (2514) 2514
risk factors (2503) 2503
care and treatment (2438) 2438
child (2219) 2219
survival analysis (2155) 2155
research (2098) 2098
disease-free survival (1997) 1997
tumors (1976) 1976
transplantation (1974) 1974
leukemia (1896) 1896
young adult (1892) 1892
neoplasm staging (1846) 1846
health aspects (1727) 1727
follow-up studies (1695) 1695
abridged index medicus (1681) 1681
mortality (1665) 1665
patients (1596) 1596
analysis (1594) 1594
lymphoma, non-hodgkin - drug therapy (1519) 1519
combined modality therapy (1493) 1493
medicine & public health (1477) 1477
rituximab (1469) 1469
child, preschool (1437) 1437
stem cells (1397) 1397
lymphoma, large b-cell, diffuse - mortality (1380) 1380
lymphoma, non-hodgkin - pathology (1367) 1367
lymphoma, non-hodgkin - therapy (1315) 1315
cyclophosphamide - administration & dosage (1287) 1287
immunology (1255) 1255
hemic and lymphatic diseases (1218) 1218
antineoplastic agents (1193) 1193
incidence (1168) 1168
epidemiology (1099) 1099
recurrence (1080) 1080
vincristine - administration & dosage (1069) 1069
antineoplastic combined chemotherapy protocols - administration & dosage (1067) 1067
lymphoma - mortality (1057) 1057
diagnosis (1036) 1036
doxorubicin - administration & dosage (1018) 1018
medical research (1014) 1014
t cells (1012) 1012
antineoplastic combined chemotherapy protocols - adverse effects (1010) 1010
non-hodgkin's lymphoma (1002) 1002
time factors (997) 997
survival (988) 988
antineoplastic agents - therapeutic use (976) 976
remission induction (975) 975
non-hodgkin lymphoma (945) 945
transplantation, autologous (934) 934
pharmacology. drug treatments (927) 927
patient outcomes (922) 922
lymphoma, large b-cell, diffuse - drug therapy (911) 911
prednisone - administration & dosage (869) 869
infant (867) 867
medical prognosis (867) 867
hematology, oncology and palliative medicine (853) 853
hematopoietic stem cell transplantation (829) 829
cancer therapies (823) 823
cohort studies (820) 820
animals (817) 817
age factors (815) 815
pathology (795) 795
lymphoma, non-hodgkin - epidemiology (781) 781
lymphoma, large b-cell, diffuse - pathology (774) 774
bone marrow (762) 762
hematopoietic stem cells (754) 754
kaplan-meier estimate (753) 753
immunotherapy (736) 736
prospective studies (732) 732
radiotherapy (717) 717
pediatrics (716) 716
lymphoma - therapy (684) 684
multivariate analysis (680) 680
stem cell transplantation (677) 677
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19071) 19071
Japanese (154) 154
German (148) 148
French (90) 90
Spanish (90) 90
Russian (70) 70
Italian (63) 63
Chinese (57) 57
Portuguese (49) 49
Polish (33) 33
Norwegian (13) 13
Czech (7) 7
Dutch (7) 7
Hungarian (7) 7
Turkish (6) 6
Danish (4) 4
Hebrew (4) 4
Croatian (3) 3
Swedish (3) 3
Bulgarian (2) 2
Finnish (2) 2
Romanian (2) 2
Serbian (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Cause‐specific mortality among Medicare beneficiaries with newly diagnosed non‐Hodgkin lymphoma subtypes
by Hester, Laura L and Park, Steven I and Wood, William A and Stürmer, Til and Brookhart, M. Alan and Lund, Jennifer L
Cancer, ISSN 0008-543X, 04/2019, Volume 125, Issue 7, pp. 1101 - 1112
competing risks | non‐Hodgkin lymphoma | histologic subtype | comorbidity | aging | non-Hodgkin lymphoma | Life Sciences & Biomedicine | Oncology | Science & Technology | SEER Program | Medicare | Comorbidity | United States | Humans | Lymphoma, Follicular - mortality | Male | Cause of Death | Lymphoma, B-Cell, Marginal Zone - mortality | Burkitt Lymphoma - mortality | Incidence | Lymphoma, Large B-Cell, Diffuse - mortality | Lymphoma, Mantle-Cell - mortality | Skin Neoplasms - mortality | Aged, 80 and over | Female | Aged | Lymphoma, Non-Hodgkin - mortality | Mycosis Fungoides - mortality | Waldenstrom Macroglobulinemia - mortality | Lymphoma, T-Cell, Peripheral - mortality | Health care | Mycosis | Decision making | Mortality | Mycosis fungoides | Epidemiology | Patients | Lymphoma | Government programs | Diagnosis | Health risk assessment | Age | Hodgkin's disease | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark-a nationwide study
by Frederiksen, B.L and Dalton, S.O and Osler, M and Steding-Jessen, M and De Nully Brown, P
British journal of cancer, ISSN 0007-0920, 02/2012, Volume 106, Issue 5, pp. 988 - 995
radiotherapy | non-Hodgkin lymphoma | socioeconomic position | chemotherapy | immunotherapy | survival | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Prognosis | Health Status Disparities | Humans | Middle Aged | Male | Treatment Outcome | Lymphoma, Non-Hodgkin - epidemiology | Survival | Socioeconomic Factors | Lymphoma, Non-Hodgkin - therapy | Aged, 80 and over | Denmark - epidemiology | Healthcare Disparities | Adult | Female | Aged | Lymphoma, Non-Hodgkin - mortality | Cohort Studies | Index Medicus | Epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Contributions of subtypes of non-Hodgkin lymphoma to mortality trends
by Howlader, Nadia and Morton, Lindsay M and Feuer, Eric J and Besson, Caroline and Engels, Eric A
Cancer epidemiology, biomarkers & prevention, ISSN 1055-9965, 01/2016, Volume 25, Issue 1, pp. 174 - 179
Oncology | Public, Environmental & Occupational Health | Life Sciences & Biomedicine | Science & Technology | United States - epidemiology | SEER Program | Prognosis | Age Factors | Follow-Up Studies | Humans | Lymphoma, Follicular - diagnosis | Lymphoma, Follicular - mortality | Survival Rate | Mortality - trends | Lymphoma, T-Cell, Peripheral - epidemiology | Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology | Incidence | Lymphoma, Large B-Cell, Diffuse - mortality | Lymphoma, Large B-Cell, Diffuse - diagnosis | Lymphoma, Follicular - epidemiology | Lymphoma, T-Cell, Peripheral - diagnosis | Lymphoma, Large B-Cell, Diffuse - epidemiology | Adult | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Neoplasm Staging | Lymphoma, T-Cell, Peripheral - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Index Medicus | Histologic Subtypes | Incidence-based mortality | Non-Hodgkin lymphoma tumor subtype trends | Partition mortality trends | SEER Registries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Non‐Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011
by Al‐Hamadani, Mohammed and Habermann, Thomas M and Cerhan, James R and Macon, William R and Maurer, Matthew J and Go, Ronald S
American journal of hematology, ISSN 0361-8609, 09/2015, Volume 90, Issue 9, pp. 790 - 795
Life Sciences & Biomedicine | Hematology | Science & Technology | United States | Humans | Middle Aged | Lymphoma, Follicular - diagnosis | Lymphoma, Mantle-Cell - pathology | Leukemia, Hairy Cell - mortality | Male | Lymphoma, B-Cell, Marginal Zone - mortality | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Lymphoma, Mantle-Cell - mortality | Lymphoma, Mantle-Cell - diagnosis | Lymphoma, Large-Cell, Anaplastic - diagnosis | Adult | Female | Lymphoma, B-Cell, Marginal Zone - pathology | B-Lymphocytes - pathology | T-Lymphocytes - pathology | Leukemia, Hairy Cell - pathology | Databases, Factual | Lymphoma, Follicular - pathology | Lymphoma, Follicular - mortality | Terminology as Topic | Burkitt Lymphoma - diagnosis | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Lymphoma, Large-Cell, Anaplastic - mortality | Leukemia, Hairy Cell - diagnosis | Lymphoma, B-Cell, Marginal Zone - diagnosis | Survival Analysis | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Lymphoma, Large-Cell, Anaplastic - pathology | Longitudinal Studies | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Databases | Non-Hodgkin's lymphomas | Native Americans | T cells | Analysis | Leukemia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study
by Younes, Anas, Prof and Thieblemont, Catherine, Prof and Morschhauser, Franck, Prof and Flinn, Ian, MD and Friedberg, Jonathan W, Prof and Amorim, Sandy, MD and Hivert, Benedicte, MD and Westin, Jason, MD and Vermeulen, Jessica, MD and Bandyopadhyay, Nibedita, PhD and de Vries, Ronald, MSc and Balasubramanian, Sriram, PhD and Hellemans, Peter, MD and Smit, Johan W, PhD and Fourneau, Nele and Oki, Yasuhiro, MD
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 1019 - 1026
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Pyrazoles - therapeutic use | Prognosis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Dose-Response Relationship, Drug | Young Adult | Non-Randomized Controlled Trials as Topic | Aged, 80 and over | Adult | Female | Lymphoma, Non-Hodgkin - drug therapy | Pyrazoles - adverse effects | Severity of Illness Index | Antigens, CD20 - immunology | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Administration, Oral | Rituximab | Survival Rate | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Antigens, CD20 - drug effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Lymphoma, Non-Hodgkin - diagnosis | Care and treatment | Anthracyclines | Cyclophosphamide | Prednisone | Corticosteroids | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma
by Flinn, Ian W and Kahl, Brad S and Leonard, John P and Furman, Richard R and Brown, Jennifer R and Byrd, John C and Wagner-Johnston, Nina D and Coutre, Steve E and Benson, Don M and Peterman, Sissy and Cho, Yoonjin and Webb, Heather K and Johnson, David M and Yu, Albert S and Ulrich, Roger G and Godfrey, Wayne R and Miller, Langdon L and Spurgeon, Stephen E
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 22, pp. 3406 - 3413
Life Sciences & Biomedicine | Hematology | Science & Technology | Humans | Middle Aged | Salvage Therapy | Quinazolinones - administration & dosage | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Purines - administration & dosage | Neoplasm Grading | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Purines - adverse effects | Purines - therapeutic use | Lymphoma, Non-Hodgkin - drug therapy | Quinazolinones - pharmacokinetics | Purines - pharmacokinetics | Treatment Outcome | Class Ia Phosphatidylinositol 3-Kinase - antagonists & inhibitors | Aged | Lymphoma, Non-Hodgkin - mortality | Quinazolinones - therapeutic use | Quinazolinones - adverse effects | Lymphoma, Non-Hodgkin - diagnosis | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Second primary cancers in non‐Hodgkin lymphoma: Family history and survival
by Chattopadhyay, Subhayan and Zheng, Guoqiao and Sud, Amit and Sundquist, Kristina and Sundquist, Jan and Försti, Asta and Houlston, Richard and Hemminki, Akseli and Hemminki, Kari
International journal of cancer, ISSN 0020-7136, 02/2020, Volume 146, Issue 4, pp. 970 - 976
prognostic grouping | second cancers | familial risk | prevention | survival | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Kaplan-Meier Estimate | Family Health | Female | Male | Neoplasms, Second Primary - mortality | Lymphoma, Non-Hodgkin - mortality | Sweden - epidemiology | Neoplasms, Second Primary - pathology | Lymphoma, Non-Hodgkin - pathology | Databases, Factual | Health risks | Risk reduction | Family medical history | Risk analysis | Lymphoma | Survival | Risk factors | Medical prognosis | Genetics | Risk management | Hodgkin's disease | Target detection | Cancer | Index Medicus | Hälsovetenskap | Medical and Health Sciences | Medicin och hälsovetenskap | Public Health, Global Health, Social Medicine and Epidemiology | Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi | Klinisk medicin | Clinical Medicine | Cancer and Oncology | Cancer och onkologi | Health Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Non-Hodgkin Lymphoma: Diagnosis and Treatment
by Ansell, Stephen M., MD, PhD
Mayo Clinic proceedings, ISSN 0025-6196, 2015, Volume 90, Issue 8, pp. 1152 - 1163
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lymphoma, Non-Hodgkin - mortality | Prognosis | Neoplasm Staging | Lymphoma, Non-Hodgkin - therapy | Humans | Lymphoma, Non-Hodgkin - diagnosis | Complications and side effects | Care and treatment | Stem cells | Transplantation | Non-Hodgkin's lymphomas | Diagnosis | Research | Health aspects | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350
by Mahadevan, Daruka and Unger, Joseph M and Spier, Catherine M and Persky, Daniel O and Young, Fay and Leblanc, Michael and Fisher, Richard I and Miller, Thomas P
Cancer, ISSN 0008-543X, 01/2013, Volume 119, Issue 2, pp. 371 - 379
angioimmunoblastic T-cell lymphoma | not otherwise specified | peripheral T-cell lymphoma | anaplastic lymphoma kinase-negative anaplastic large cell lymphoma | multidrug resistant proteins | chemotherapy | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Lymphoma, T-Cell, Peripheral - drug therapy | Deoxycytidine - administration & dosage | Humans | Middle Aged | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Kaplan-Meier Estimate | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Etoposide - administration & dosage | Male | Treatment Outcome | Cisplatin - administration & dosage | Young Adult | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell, Peripheral - metabolism | Lymphoma, T-Cell, Peripheral - pathology | Aged, 80 and over | Adult | Female | Aged | Neoplasm Staging | Lymphoma, T-Cell, Peripheral - mortality | Deoxycytidine - analogs & derivatives | Methylprednisolone - administration & dosage | Antimitotic agents | T cell lymphoma | Patient outcomes | Dosage and administration | Research | Drug therapy | Antineoplastic agents | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights